SCHEMBL4452002

SCHEMBL4452002

Cc1ccc(S(=O)(=O)OC(CN)(c2ccc(Cl)cc2)c2ccc(I)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP3 O14638 1/20 0.38
ENPP1 P22413 1/20 0.38
ENPP2 Q13822 1/20 0.38
BCHE P06276 1/20 0.37
ACHE P22303 1/20 0.37
CNR2 P34972 3/20 0.36
ALDH1A1 P00352 2/20 0.36
LMNA P02545 2/20 0.36
MAPT P10636 4/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
TSHR P16473 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
KMT2A Q03164 4/20 0.35
EGFR P00533 1/20 0.34
ERBB2 P04626 1/20 0.34
GAA P10253 1/20 0.34
MEN1 O00255 1/20 0.34
CNR1 P21554 2/20 0.34
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL850796 1.00 ENPP3 (0.38) ENPP3ENPP1ENPP2BCHEACHE
SCHEMBL850795 0.75 CYP1A2 (0.44) BCHEACHECNR2LMNAMAPT
SCHEMBL12173962 0.72 KMT2A (0.42) ENPP3ENPP1ENPP2BCHEACHE
SCHEMBL3254569 0.72 ENPP3 (0.43) ENPP3ENPP1ENPP2BCHEACHE
SCHEMBL10838189 0.70 GRIN2D (0.43) ENPP3ENPP1ENPP2BCHEACHE
SCHEMBL6004113 0.68 ENPP3 (0.42) ENPP3ENPP1ENPP2BCHEACHE
SCHEMBL5314186 0.68 BCHE (0.54) ENPP3ENPP1ENPP2BCHEACHE
SCHEMBL4656029 0.67 VDR (0.42) BCHEACHECNR2ALDH1A1LMNA
SCHEMBL28078113 0.67 CES2 (0.50) ACHELMNATDP1KMT2AMEN1
SCHEMBL11022325 0.66 ENPP3 (0.43) ENPP3ENPP1ENPP2BCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101686965-B Compositions comprising (s)-2-amino-1-(4-chlorophenyl)-1-[4-(1h-pyrazol-4-yl)-phenyl]-ethanol as modulator of protein kinases ASTEX THERAPEUTICS LTD 2014-09-17 CN disclosed
CN-101686965-A Compositions comprising (s)-2-amino-1-(4-chlorophenyl)-1-[4-(1h-pyrazol-4-yl)-phenyl]-ethanol as modulator of protein kinases ASTEX THERAPEUTICS LTD 2010-03-31 CN disclosed
EP-2134339-A2 COMPOSITIONS COMPRISING (S)-2-AMINO-1-(4-CHLOROPHENYL)-1-[4-(1H-PYRAZOL-4-YL)-PHENYL]-ETHANOL AS MODULATOR OF PROTEIN KINASES Astex Therapeutics Limited (GB) 2009-12-23 EP disclosed
WO-2008110846-A2 COMPOSITIONS COMPRISING (S)-2-AMINO-1-(4-CHLOROPHENYL)-1-[4-(1H-PYRAZOL-4-YL)-PHENYL]-ETHANOL AS MODULATOR OF PROTEIN KINASES ASTEX THERAPEUTICS LIMITED (GB) 2008-09-18 WO disclosed